Last reviewed · How we verify
Merislon
At a glance
| Generic name | Merislon |
|---|---|
| Sponsor | Zhan Yunfan |
| Target | Histamine H3 receptor, Histamine H3 receptor |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Ménière's disease
Common side effects
Key clinical trials
- Safety and Efficacy of Shi's Traumatology Osteopathic Manipulative Treatment for Cervicogenic Dizziness (NA)
- Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease
- Laser Acupuncture for Meniere Disease (PHASE2)
- Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease (NA)
- A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |